Impairment endothelium-dependent pulmonary-artery relaxation chronic obstructive lung disease BACKGROUND Endothelial cells endothelium-derived relaxing factor EDRF variety vascular beds pulmonary circulation role EDRF-mediated pulmonary-artery relaxation chronic hypoxic lung disease unknown METHODS endothelium-dependent relaxation EDRF vitro pulmonary arteries patients undergoing heart-lung transplantation end-stage chronic obstructive lung disease Control pulmonary arteries patients undergoing lobectomy lung carcinoma evidence chronic lung disease responses vascular rings external diameter mm endothelium-dependent vasodilators diphosphate lung excision RESULTS Pulmonary arterial rings patients chronic lung disease tension response rings control patients Inhibition EDRF synthesis treatment NG-monomethyl-L-arginine difference tension rings controls patients chronic lung disease Rings control patients response cumulative doses acetylcholine maximal relaxation percent adenosine diphosphate maximal relaxation percent contrast rings patients chronic obstructive lung disease percent maximal relaxation response percent response diphosphate control rings Rings controls patients chronic lung disease response endothelium-independent vasodilator sodium nitroprusside inverse correlation degree intimal thickening level maximal relaxation rings patients chronic lung disease Maximal relaxation partial pressure arterial oxygen transplantation partial pressure arterial carbon dioxide transplantation forced expiratory volume second significant CONCLUSIONS Endothelium-dependent pulmonary-artery relaxation vitro arteries patients end-stage chronic obstructive lung disease Such impairment development pulmonary hypertension chronic hypoxic lung disease 